Transaction · 0001464583-26-000010

Megna Michael R

Megna Michael R, CAO, reported a transaction classified as exercise at Kiniksa Pharmaceuticals International, plc involving 4689.000000 shares for an estimated $0.00. Reported holdings after the transaction were 2983.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCAO
KNSAKiniksa Pharmaceuticals International, plc
Trade date
Oct 30, 2026
Filing date
Nov 03, 2026
View on SEC Insider profile
Disclosed value$0Shares × reported price
Shares traded4.68k$0.00 per share
Holdings after2.98kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

KNSA price since this filing

Daily closing prices, with the filing date and available return windows
KNSA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -21.6%1w ago -19.4%1d ago +0.0%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001464583-26-000010
Share Option
Transaction date
Oct 30, 2026
Filed Nov 03, 2026, 11:26 PM · 4d delay
Shares
4,689 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
2,983 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Reduction 10b5-1 Detected
Filing-only score

-20 points

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF ACCOUNTING OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 30, 2026.

  2. F2

    This transaction was executed in multiple trades through a broker-dealer at prices ranging between $91.275 and $92.26. The price reported in this column reflects a weighted average sales price. Upon r…

  3. F3

    This transaction was executed in multiple trades through a broker-dealer at prices ranging between $92.28 and $93.27. The price reported in this column reflects a weighted average sales price. Upon re…

  4. F4

    This transaction was executed in multiple trades through a broker-dealer at prices ranging between $93.42 and $94.38. The price reported in this column reflects a weighted average sales price. Upon re…

  5. F5

    This transaction was executed in multiple trades through a broker-dealer at prices ranging between $94.42 and $95.22. The price reported in this column reflects a weighted average sales price. Upon re…

  6. F6

    This transaction was executed in multiple trades through a broker-dealer at prices ranging between $95.485 and $96.405. The price reported in this column reflects a weighted average sales price. Upon…

  7. F7

    This transaction was executed in multiple trades through a broker-dealer at prices ranging between $96.565 and $97.50. The price reported in this column reflects a weighted average sales price. Upon r…

  8. F8

    This transaction was executed in multiple trades through a broker-dealer at prices ranging between $97.60 and $98.48. The price reported in this column reflects a weighted average sales price. Upon re…

  9. F9

    The option is fully vested and exercisable.

  10. F10

    The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting comme…

  11. F11

    The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting comme…

Original filing · 0001464583-26-000010
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

KNSA